These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10373643)

  • 1. T cell regeneration in HIV-infected subjects under highly active antiretroviral therapy (review).
    Fleury S; Pantaleo G
    Int J Mol Med; 1999 Jul; 4(1):91-7. PubMed ID: 10373643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term kinetics of T cell production in HIV-infected subjects treated with highly active antiretroviral therapy.
    Fleury S; Rizzardi GP; Chapuis A; Tambussi G; Knabenhans C; Simeoni E; Meuwly JY; Corpataux JM; Lazzarin A; Miedema F; Pantaleo G
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5393-8. PubMed ID: 10805798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues.
    Bucy RP; Hockett RD; Derdeyn CA; Saag MS; Squires K; Sillers M; Mitsuyasu RT; Kilby JM
    J Clin Invest; 1999 May; 103(10):1391-8. PubMed ID: 10330421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple CD4+ cell kinetic patterns and their relationships with baseline factors and virological responses in HIV type 1 patients receiving highly active antiretroviral therapy.
    Wu H; Connick E; Kuritzkes DR; Landay A; Spritzler J; Zhang B; Spear GT; Kessler H; Lederman MM;
    AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1231-40. PubMed ID: 11559422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cells.
    Al-Harthi L; Voris J; Du W; Wright D; Nowicki M; Frederick T; Landay A; Kovacs A
    J Infect Dis; 2006 May; 193(9):1202-10. PubMed ID: 16586355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease in immune activation in HIV-infected patients treated with highly active antiretroviral therapy correlates with the function of hematopoietic progenitor cells and the number of naive CD4+ cells.
    Nielsen SD; Sørensen TU; Ersbøll AK; Ngo N; Mathiesen L; Nielsen JO; Hansen JE
    Scand J Infect Dis; 2000; 32(6):597-603. PubMed ID: 11200367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience.
    Gray CM; Schapiro JM; Winters MA; Merigan TC
    AIDS Res Hum Retroviruses; 1998 May; 14(7):561-9. PubMed ID: 9591710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower CD4+ T lymphocyte nadirs may indicate limited immune reconstitution in HIV-1 infected individuals on potent antiretroviral therapy: analysis of immunophenotypic marker results of AACTG 5067.
    D'Amico R; Yang Y; Mildvan D; Evans SR; Schnizlein-Bick CT; Hafner R; Webb N; Basar M; Zackin R; Jacobson MA
    J Clin Immunol; 2005 Mar; 25(2):106-15. PubMed ID: 15821887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normalization of CD4+ cell numbers and reduced levels of memory CD8+ cells in blood and tonsillar tissue after highly active antiretroviral therapy in early HIV type-1 infection.
    Dyrhol-Riise AM; Voltersvik P; Røsok BI; Olofsson J; Asjö B
    AIDS Res Hum Retroviruses; 2000 Feb; 16(3):191-201. PubMed ID: 10710207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy.
    Guadalupe M; Reay E; Sankaran S; Prindiville T; Flamm J; McNeil A; Dandekar S
    J Virol; 2003 Nov; 77(21):11708-17. PubMed ID: 14557656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy.
    Benito JM; López M; Lozano S; González-Lahoz J; Soriano V
    J Infect Dis; 2008 Nov; 198(10):1466-73. PubMed ID: 18847371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues.
    Haase AT
    Annu Rev Immunol; 1999; 17():625-56. PubMed ID: 10358770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Premature immunosenescence in HIV-infected patients on highly active antiretroviral therapy with low-level CD4 T cell repopulation.
    Molina-Pinelo S; Vallejo A; Díaz L; Soriano-Sarabia N; Ferrando-Martínez S; Resino S; Muñoz-Fernández MA; Leal M
    J Antimicrob Chemother; 2009 Sep; 64(3):579-88. PubMed ID: 19608579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of highly active antiretroviral treatment on expression of HIV-1 coreceptors and ligand levels in peripheral blood from HIV-1 infected patients in China.
    Fang J; Bai S; Wu L; Zhu X; Yao X; Jin C; Wang C
    J Int Med Res; 2013 Oct; 41(5):1560-9. PubMed ID: 24043708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central memory CD4+ T cell responses in chronic HIV infection are not restored by antiretroviral therapy.
    Elrefaei M; McElroy MD; Preas CP; Hoh R; Deeks S; Martin J; Cao H
    J Immunol; 2004 Aug; 173(3):2184-9. PubMed ID: 15265956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART.
    Marchetti G; Gori A; Casabianca A; Magnani M; Franzetti F; Clerici M; Perno CF; Monforte Ad; Galli M; Meroni L
    AIDS; 2006 Aug; 20(13):1727-36. PubMed ID: 16931937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological changes in peripheral blood and in lymphoid tissue after treatment of HIV-infected subjects with highly active anti-retroviral therapy (HAART) or HAART + IL-2.
    Zanussi S; Simonelli C; Bortolin MT; D'Andrea M; Crepaldi C; Vaccher E; Nasti G; Politi D; Barzan L; Tirelli U; De Paoli P
    Clin Exp Immunol; 1999 Jun; 116(3):486-92. PubMed ID: 10361239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific patterns of CD4-associated immunosenescence in vertically HIV-infected subjects.
    Méndez-Lagares G; Díaz L; Correa-Rocha R; León Leal JA; Ferrando-Martínez S; Ruiz-Mateos E; Pozo-Balado MM; Gurbindo MD; de José MI; Muñoz-Fernández MA; Leal M; Pacheco YM
    Clin Microbiol Infect; 2013 Jun; 19(6):558-65. PubMed ID: 22735071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased ex vivo cell death of central memory CD4 T cells in treated HIV infected individuals with unsatisfactory immune recovery.
    Massanella M; Gómez-Mora E; Carrillo J; Curriu M; Ouchi D; Puig J; Negredo E; Cabrera C; Clotet B; Blanco J
    J Transl Med; 2015 Jul; 13():230. PubMed ID: 26183947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4 lymphocytes in the blood of HIV(+) individuals migrate rapidly to lymph nodes and bone marrow: support for homing theory of CD4 cell depletion.
    Chen JJ; Huang JC; Shirtliff M; Briscoe E; Ali S; Cesani F; Paar D; Cloyd MW
    J Leukoc Biol; 2002 Aug; 72(2):271-8. PubMed ID: 12149417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.